000 01549 a2200397 4500
005 20250514020730.0
264 0 _c20020114
008 200201s 0 0 eng d
022 _a0022-1007
024 7 _a10.1084/jem.194.12.1755
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKakimi, K
245 0 0 _aBlocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.
_h[electronic resource]
260 _bThe Journal of experimental medicine
_cDec 2001
300 _a1755-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aChemokine CXCL10
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHepatitis B
_xgenetics
650 0 4 _aHepatitis B virus
_ximmunology
650 0 4 _aInterferon-gamma
_xgenetics
650 0 4 _aLiver
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aMonokines
_xgenetics
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
700 1 _aLane, T E
700 1 _aWieland, S
700 1 _aAsensio, V C
700 1 _aCampbell, I L
700 1 _aChisari, F V
700 1 _aGuidotti, L G
773 0 _tThe Journal of experimental medicine
_gvol. 194
_gno. 12
_gp. 1755-66
856 4 0 _uhttps://doi.org/10.1084/jem.194.12.1755
_zAvailable from publisher's website
999 _c11661080
_d11661080